Cargando…

Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis

The renin-angiotensin-aldosterone system (RAAS) blockers have been widely used in chronic kidney disease patients undergoing hemodialysis; however, whether RAAS blockers have beneficial effects for cardiovascular disease in those patients has not been fully defined. This review focuses on the effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Morishita, Yoshiyuki, Kusano, Eiji, Nagata, Daisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944431/
https://www.ncbi.nlm.nih.gov/pubmed/24611082
http://dx.doi.org/10.2174/1874192401408010006
_version_ 1782306380648022016
author Morishita, Yoshiyuki
Kusano, Eiji
Nagata, Daisuke
author_facet Morishita, Yoshiyuki
Kusano, Eiji
Nagata, Daisuke
author_sort Morishita, Yoshiyuki
collection PubMed
description The renin-angiotensin-aldosterone system (RAAS) blockers have been widely used in chronic kidney disease patients undergoing hemodialysis; however, whether RAAS blockers have beneficial effects for cardiovascular disease in those patients has not been fully defined. This review focuses on the effects of RAAS blockers in chronic kidney disease undergoing hemodialysis for cardiovascular disease.
format Online
Article
Text
id pubmed-3944431
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Bentham Open
record_format MEDLINE/PubMed
spelling pubmed-39444312014-03-07 Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis Morishita, Yoshiyuki Kusano, Eiji Nagata, Daisuke Open Cardiovasc Med J Article The renin-angiotensin-aldosterone system (RAAS) blockers have been widely used in chronic kidney disease patients undergoing hemodialysis; however, whether RAAS blockers have beneficial effects for cardiovascular disease in those patients has not been fully defined. This review focuses on the effects of RAAS blockers in chronic kidney disease undergoing hemodialysis for cardiovascular disease. Bentham Open 2014-02-07 /pmc/articles/PMC3944431/ /pubmed/24611082 http://dx.doi.org/10.2174/1874192401408010006 Text en © Morishita et al.; Licensee Bentham Open. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Morishita, Yoshiyuki
Kusano, Eiji
Nagata, Daisuke
Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis
title Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis
title_full Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis
title_fullStr Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis
title_full_unstemmed Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis
title_short Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis
title_sort clinical implication of the renin-angiotensin-aldosterone blockers in chronic kidney disease undergoing hemodialysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944431/
https://www.ncbi.nlm.nih.gov/pubmed/24611082
http://dx.doi.org/10.2174/1874192401408010006
work_keys_str_mv AT morishitayoshiyuki clinicalimplicationofthereninangiotensinaldosteroneblockersinchronickidneydiseaseundergoinghemodialysis
AT kusanoeiji clinicalimplicationofthereninangiotensinaldosteroneblockersinchronickidneydiseaseundergoinghemodialysis
AT nagatadaisuke clinicalimplicationofthereninangiotensinaldosteroneblockersinchronickidneydiseaseundergoinghemodialysis